Article
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
array:24 [ "pii" => "S2253808920300203" "issn" => "22538089" "doi" => "10.1016/j.remnie.2020.01.008" "estado" => "S300" "fechaPublicacion" => "2020-07-01" "aid" => "1127" "copyright" => "Sociedad Española de Medicina Nuclear e Imagen Molecular" "copyrightAnyo" => "2020" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Rev Esp Med Nucl Imagen Mol. 2020;39:244-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S2253654X20300032" "issn" => "2253654X" "doi" => "10.1016/j.remn.2020.01.001" "estado" => "S300" "fechaPublicacion" => "2020-07-01" "aid" => "1127" "copyright" => "Sociedad Española de Medicina Nuclear e Imagen Molecular" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Rev Esp Med Nucl Imagen Mol. 2020;39:244-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Imágenes de interés</span>" "titulo" => "Utilidad de la PET con <span class="elsevierStyleSup">68</span>Ga-DOTATOC en la búsqueda del tumor primario en pacientes con metástasis hepáticas de origen neuroendocrino. A propósito de un caso" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "244" "paginaFinal" => "245" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Diagnostic value of <span class="elsevierStyleSup">68</span>Ga-DOTATOC PET in the localization of primary tumor in patients with liver metastases of neuroendocrine origin but unknown primary. About a case" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figura 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1172 "Ancho" => 1674 "Tamanyo" => 209167 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Imágenes seleccionadas PET/RM con 68Ga-DOTATOC.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "S. Ortiz, J.R. García, E. Riera, M. Soler, A. Compte Montañez, E. Valls" "autores" => array:6 [ 0 => array:2 [ "nombre" => "S." "apellidos" => "Ortiz" ] 1 => array:2 [ "nombre" => "J.R." "apellidos" => "García" ] 2 => array:2 [ "nombre" => "E." "apellidos" => "Riera" ] 3 => array:2 [ "nombre" => "M." "apellidos" => "Soler" ] 4 => array:2 [ "nombre" => "A." "apellidos" => "Compte Montañez" ] 5 => array:2 [ "nombre" => "E." "apellidos" => "Valls" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2253808920300203" "doi" => "10.1016/j.remnie.2020.01.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2253808920300203?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2253654X20300032?idApp=UINPBA00004N" "url" => "/2253654X/0000003900000004/v2_202007180736/S2253654X20300032/v2_202007180736/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2253808920300082" "issn" => "22538089" "doi" => "10.1016/j.remnie.2020.01.006" "estado" => "S300" "fechaPublicacion" => "2020-07-01" "aid" => "1126" "copyright" => "Sociedad Española de Medicina Nuclear e Imagen Molecular" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Rev Esp Med Nucl Imagen Mol. 2020;39:246-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Interesting images</span>" "titulo" => "Incidental finding of ectopic thyroid gland in the study of a patient with primary hyperparathyroidism" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "246" "paginaFinal" => "247" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Hallazgo incidental de glándula tiroides ectópica en estudio de paciente con hiperparatiroidismo primario" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2571 "Ancho" => 2500 "Tamanyo" => 396722 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0070" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">SPECT/CT images (one hour after <span class="elsevierStyleSup">99m</span>Tc-sestamibi injection) show parathyroid adenoma (red star) of left paratracheal location (A, SPECT and B, fusion with CT) and a 3<span class="elsevierStyleHsp" style=""></span>cm mass (C, SPECT and D, fusion with CT) corresponding to sublingual ectopic thyroid gland (blue arrow) with a practically complete washout of the tracer.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M.B. Tagliatori-Nogueira, L. Castillejos-Rodríguez, M. de la Rubia-Marcos, C.F. Mena-Melgar, B. Manzarbeitia-Arroba, M.Á. Balsa-Bretón" "autores" => array:6 [ 0 => array:2 [ "nombre" => "M.B." "apellidos" => "Tagliatori-Nogueira" ] 1 => array:2 [ "nombre" => "L." "apellidos" => "Castillejos-Rodríguez" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "de la Rubia-Marcos" ] 3 => array:2 [ "nombre" => "C.F." "apellidos" => "Mena-Melgar" ] 4 => array:2 [ "nombre" => "B." "apellidos" => "Manzarbeitia-Arroba" ] 5 => array:2 [ "nombre" => "M.Á." "apellidos" => "Balsa-Bretón" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S2253654X20300020" "doi" => "10.1016/j.remn.2019.12.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2253654X20300020?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2253808920300082?idApp=UINPBA00004N" "url" => "/22538089/0000003900000004/v1_202008190628/S2253808920300082/v1_202008190628/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2253808920300616" "issn" => "22538089" "doi" => "10.1016/j.remnie.2020.06.002" "estado" => "S300" "fechaPublicacion" => "2020-07-01" "aid" => "1180" "copyright" => "Sociedad Española de Medicina Nuclear e Imagen Molecular" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Rev Esp Med Nucl Imagen Mol. 2020;39:233-43" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Special collaboration</span>" "titulo" => "Functional imaging in soft tissue sarcomas: Update of the indications for <span class="elsevierStyleSup">18</span>F-FDG-PET/CT" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "233" "paginaFinal" => "243" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Imagen funcional en sarcomas de partes blandas: actualización de las indicaciones de la <span class="elsevierStyleSup">18</span>F-FDG-PET/TC" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Fig. 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 804 "Ancho" => 1755 "Tamanyo" => 153614 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">A 38-year-old patient suspected of extraosseous Ewing sarcoma. Three biopsies were performed (A), with the result of insufficient tissue and inconclusive diagnosis. After the acquisition of a PET/CT study (B), a new biopsy was attempted, directed at the more hypermetabolic solid component of the mass (C), the result of which confirmed the diagnosis of suspicion.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "B. Rodríguez-Alfonso, M. Simó-Perdigó, J. Orcajo Rincón" "autores" => array:3 [ 0 => array:2 [ "nombre" => "B." "apellidos" => "Rodríguez-Alfonso" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "Simó-Perdigó" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Orcajo Rincón" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S2253654X20300883" "doi" => "10.1016/j.remn.2020.06.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2253654X20300883?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2253808920300616?idApp=UINPBA00004N" "url" => "/22538089/0000003900000004/v1_202008190628/S2253808920300616/v1_202008190628/en/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Interesting images</span>" "titulo" => "Diagnostic value of <span class="elsevierStyleSup">68</span>Ga-DOTATOC PET in the localization of primary tumor in patients with liver metastases of neuroendocrine origin but unknown primary. About a case" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "244" "paginaFinal" => "245" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "S. Ortiz, J.R. García, E. Riera, M. Soler, A. Compte Montañez, E. Valls" "autores" => array:6 [ 0 => array:4 [ "nombre" => "S." "apellidos" => "Ortiz" "email" => array:1 [ 0 => "sortiz@cetir.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "J.R." "apellidos" => "García" ] 2 => array:2 [ "nombre" => "E." "apellidos" => "Riera" ] 3 => array:2 [ "nombre" => "M." "apellidos" => "Soler" ] 4 => array:2 [ "nombre" => "A." "apellidos" => "Compte Montañez" ] 5 => array:2 [ "nombre" => "E." "apellidos" => "Valls" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Unidad PET/RM Viladomat, CETIR-ASCIRES GRUPO BIOMÉDICO, Barcelona, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Utilidad de la PET con <span class="elsevierStyleSup">68</span>Ga-DOTATOC en la búsqueda del tumor primario en pacientes con metástasis hepáticas de origen neuroendocrino. A propósito de un caso" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 973 "Ancho" => 2000 "Tamanyo" => 110894 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A: 111In-octreotide SPECT/C, B: <span class="elsevierStyleSup">18</span>F-FDG PET/CT, C : A <span class="elsevierStyleSup">68</span>Ga-DOTATOC PET/MRI, performed over the course of one month. Detection of a higher number of of lesions with <span class="elsevierStyleSup">68</span>Ga-DOTATOC PET/MRI.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">A case of a 59-year-old female patient who consulted the emergency department for abdominal pain is presented. Non-contrast CT scan depicted acute cholecystitis and a non-specific hepatic lesion next to gallbladder that suggested adjacent abscess. Treatment of acute symptoms and follow-up was recommended. One month after treatment, and with patient being asymptomatic, an enhanced CT scan with iv contrast was performed, which showed infiltrative lesions in hepatic segments IV, V, VI and caudate lobe, which were confirmed on a subsequent MRI study. Biopsy histopathology confirmed a low-grade neuroendocrine tumour (NET), Ki67 1%–2%. Cromogranine A was negative.</p><p id="par0010" class="elsevierStylePara elsevierViewall">NET lesions are usually low-aggressive. However, 40% of cases may present with metastases at diagnosis, with unknown primary in more than 10% of cases.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a> Higher survival has been reported among those patients with primary identified and amenable to surgical treatment.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Diagnostic procedures include three-phase CT, MRI and SPECT/CT with somatostatin analogues (labelled with either <span class="elsevierStyleSup">99m</span>Tc or <span class="elsevierStyleSup">111</span>In). In our case, no extra-hepatic lesions were detected on CT or MRI. <span class="elsevierStyleSup">111</span>In-Octreotide SPECT/CT did not identified primary tumour either, and showed only tracer uptake in liver metastases (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>.1).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Despite the well-known low affinity of <span class="elsevierStyleSup">18</span>F-FDG for differentiated NET detection, in our case given its availability, and since an undifferentiated primary tumour was suspected due to fast liver involvement, a <span class="elsevierStyleSup">18</span>F-FDG PET/CT was eventually performed, which showed liver metastases uptake, and no primary tumour was either detected (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>.2).</p><p id="par0020" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleSup">68</span>Ga-DOTATOC PET has demonstrated a higher sensitivity than CT, MRI and SPECT/CT with somatostatin analogues altogether in NET detection, with better lymph nodes and metastasis staging performance, as well as higher primary tumour identification, for which is an appropriate procedure to perform.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> This procedure is usually performed whenever the remaining tests are negative, based on its availability and healthcare management issues. However, we feel that this approach should be reconsidered in the future. PET/MRI has shown a better performance for liver disease staging, and diffusion sequences may confirm pathologic lymph node uptake.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">A <span class="elsevierStyleSup">68</span>Ga-DOTATOC PET/MRI (Signa, GE) was performed, which depicted a higher number of liver metastases, and a focal uptake in pelvic ileal loops, consistent with primary tumour, as well as a mesenteric lymph node with <span class="elsevierStyleSup">68</span>Ga-DOTATOC uptake and restriction of diffusion (<a class="elsevierStyleCrossRef" href="#fig0005">Figs. 1</a>.3 and <a class="elsevierStyleCrossRef" href="#fig0010">2</a>). Ileal resection histopathology confirmed a well-differentiated low-grade NET, G1, Ki67 2%, synaptophysin positive, and with lymph node involvement, and lanreotide treatment was also delivered.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">In our case, after conventional procedures and <span class="elsevierStyleSup">18</span>F-FDG PET/CT, which all failed to identify the primary tumour, subsequent <span class="elsevierStyleSup">68</span>Ga-DOTATOC PET/MRI allowed for the adequate disease staging, including primary tumour detection and lymph node involvement with therapy implications, and patient therefore underwent surgery and treatment with somatostatin analogues.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Ortiz S, García JR, Riera E, Soler M, Compte Montañez A, Valls E. Utilidad de la PET con <span class="elsevierStyleSup">68</span>Ga-DOTATOC en la búsqueda del tumor primario en pacientes con metástasis hepáticas de origen neuroendocrino. A propósito de un caso. Rev Esp Med Nucl Imagen Mol. 2020;39:244–245.</p>" ] ] "multimedia" => array:2 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 973 "Ancho" => 2000 "Tamanyo" => 110894 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A: 111In-octreotide SPECT/C, B: <span class="elsevierStyleSup">18</span>F-FDG PET/CT, C : A <span class="elsevierStyleSup">68</span>Ga-DOTATOC PET/MRI, performed over the course of one month. Detection of a higher number of of lesions with <span class="elsevierStyleSup">68</span>Ga-DOTATOC PET/MRI.</p>" ] ] 1 => array:8 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1172 "Ancho" => 1674 "Tamanyo" => 209167 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleSup">68</span>Ga-DOTATOC PET/MRI. A: Detection of a higher number of liver metastases. B-C: Somatostatin receptor overexpression spot (focal uptake) in pelvic ileal loops (Fat arrow). D-E-F: 7 mm mesenteric lymph node with <span class="elsevierStyleSup">68</span>Ga-DOTATOC pathologic uptake and restriction of diffusion (long arrow). A well-differentiated low-grade NET with lymph node involvement have been confirmed by histopathology.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:3 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Kazmierczak" 1 => "A. Rominger" 2 => "V. Wenter" 3 => "C. Spitzweg" 4 => "C. Auernhammer" 5 => "M.K. Angele" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00330-016-4475-3" "Revista" => array:6 [ "tituloSerie" => "Eur Radiol" "fecha" => "2017" "volumen" => "27" "paginaInicial" => "1676" "paginaFinal" => "1684" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27436022" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "V. Prasad" 1 => "V. Ambrosini" 2 => "M. Hommann" 3 => "D. Hoersch" 4 => "S. Fanti" 5 => "R.P. Baum" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00259-009-1205-y" "Revista" => array:6 [ "tituloSerie" => "Eur J Nucl Med Mol Imaging" "fecha" => "2010" "volumen" => "37" "paginaInicial" => "67" "paginaFinal" => "77" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19618183" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T.A. Hope" 1 => "E.K. Bergsland" 2 => "M.F. Bozkurt" 3 => "M. Graham" 4 => "A.P. Heaney" 5 => "K. Herrmann" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2967/jnumed.117.202275" "Revista" => array:6 [ "tituloSerie" => "J Nucl Med" "fecha" => "2018" "volumen" => "59" "paginaInicial" => "66" "paginaFinal" => "74" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29025982" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/22538089/0000003900000004/v1_202008190628/S2253808920300203/v1_202008190628/en/main.assets" "Apartado" => array:4 [ "identificador" => "7927" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Interesting images" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/22538089/0000003900000004/v1_202008190628/S2253808920300203/v1_202008190628/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2253808920300203?idApp=UINPBA00004N" ]
Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación
Esté informado en todo momento gracias a las alertas y novedades
Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados
The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging, which has more than 700 members. The Journal, which publishes 6 regular issues per year, has the promotion of research and continuing education in all fields of Nuclear Medicine as its main aim. For this, its principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articles. The works may be submitted in Spanish or English and are subjected to a peer review process. In 2009, it became the leading Spanish journal in the field of Medical Imaging on having an Impact Factor , awarded by the Journal Citation Reports.
Science Citation Index Expander, Medline, IME, Bibliomed, EMBASE/Excerpta Medica, Healthstar, Cancerlit, Toxine, Inside Conferences, Scopus
See moreThe Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2022
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
See moreSNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
See moreRevista Española de Medicina Nuclear e Imagen Molecular (English Edition)
¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?
Are you a health professional able to prescribe or dispense drugs?
Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos